These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 37934614)

  • 1. Gut microbiome-targeted therapies for Alzheimer's disease.
    Zhang T; Gao G; Kwok LY; Sun Z
    Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics.
    Peterson CT
    J Evid Based Integr Med; 2020; 25():2515690X20957225. PubMed ID: 33092396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome in Alzheimer's Disease: from Mice to Humans.
    Liang C; Pereira R; Zhang Y; Rojas OL
    Curr Neuropharmacol; 2024; 22(14):2314-2329. PubMed ID: 39403057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis and Alzheimer's disease: role of probiotics, prebiotics and synbiotics.
    Thakkar A; Vora A; Kaur G; Akhtar J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2911-2923. PubMed ID: 37284896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
    Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
    Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
    Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
    Wei Y; Peng S; Lian C; Kang Q; Chen J
    Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome modulation by probiotics, prebiotics, synbiotics and postbiotics: a novel strategy in food allergy prevention and treatment.
    Shi J; Wang Y; Cheng L; Wang J; Raghavan V
    Crit Rev Food Sci Nutr; 2024; 64(17):5984-6000. PubMed ID: 36576159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
    Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
    Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease.
    Ngoc APT; Zahoor A; Kim DG; Yang SH
    J Microbiol Biotechnol; 2024 Sep; 34(9):1739-1747. PubMed ID: 39099195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Gut Microbiome: A New Frontier in Cancer Diagnostics & Therapeutics.
    Rani V; Singhal S; Sharma K; Vaid R; Aggarwal K; Bhadana R; Agarwal R; Atale N
    Curr Pharm Des; 2021; 27(45):4578-4592. PubMed ID: 34620056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
    Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
    Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's disease.
    Thu Thuy Nguyen V; Endres K
    Adv Drug Deliv Rev; 2022 Sep; 188():114418. PubMed ID: 35787390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
    Liu S; Gao J; Zhu M; Liu K; Zhang HL
    Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and its metabolites in depression: from pathogenesis to treatment.
    Liu L; Wang H; Chen X; Zhang Y; Zhang H; Xie P
    EBioMedicine; 2023 Apr; 90():104527. PubMed ID: 36963238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease.
    Peddinti V; Avaghade MM; Suthar SU; Rout B; Gomte SS; Agnihotri TG; Jain A
    Clin Nutr ESPEN; 2024 Apr; 60():266-280. PubMed ID: 38479921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.